Decorin Induces Mitophagy in Breast Carcinoma Cells via Peroxisome Proliferator-activated Receptor γ Coactivator-1α (PGC-1α) and Mitostatin
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Tumor cell mitochondria are key biosynthetic hubs that provide macromolecules for cancer progression and angiogenesis. Soluble decorin protein core, hereafter referred to as decorin, potently attenuated mitochondrial respiratory complexes and mitochondrial DNA (mtDNA) in MDA-MB-231 breast carcinoma cells. We found a rapid and dynamic interplay between peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) and the decorin-induced tumor suppressor gene, mitostatin. This interaction stabilized mitostatin mRNA with concurrent accumulation of mitostatin protein. In contrast, siRNA-mediated abrogation of PGC-1α-blocked decorin-evoked stabilization of mitostatin. Mechanistically, PGC-1α bound MITOSTATIN mRNA to achieve rapid stabilization. These processes were orchestrated by the decorin/Met axis, as blocking the Met-tyrosine kinase or knockdown of Met abrogated these responses. Furthermore, depletion of mitostatin blocked decorin- or rapamycin-evoked mitophagy, increased vascular endothelial growth factor A (VEGFA) production, and compromised decorin-evoked VEGFA suppression. Collectively, our findings underscore the complexity of PGC-1α-mediated mitochondrial homeostasis and establish mitostatin as a key regulator of tumor cell mitophagy and angiostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
Methods in Mammalian Autophagy Research
Mizushima, N., Yoshimori, T., & Levine, B. (2010) · Cell · doi:10.1016/j.cell.2010.01.028 · Cited by 4,497
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233 · cited 3×
“Altered cancer cell metabolism strictly relies on functional mitochondria, which are exploited to provide key biosynthetic precursors to aid in macromolecular synthesis via acetyl-CoA and derivatives thereof (2).”
BackgroundTumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
Negative regulation of transforming growth factor-β by the proteoglycan decorin
Yamaguchi, Y., Mann, D. M., & Ruoslahti, E. (1990) · Nature · doi:10.1038/346281a0 · Cited by 1,516
Transcriptional control of mitochondrial biogenesis: the central role of PGC-1
Ventura-Clapier, R., Garnier, A., & Veksler, V. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn098 · Cited by 932
Vazquez, F., Lim, J.-H., Chim, H., Bhalla, K., Girnun, G., Pierce, K., Clish, C. B., Granter, S. R., Widlund, H. R., Spiegelman, B. M., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.11.020 · Cited by 715
The regulatory roles of small leucine‐rich proteoglycans in extracellular matrix assembly
Chen, S., & Birk, D. E. (2013) · The FEBS Journal · doi:10.1111/febs.12136 · Cited by 378
Zhang, G., Chen, S., Goldoni, S., Calder, B. W., Simpson, H. C., Owens, R. T., McQuillan, D. J., Young, M. F., Iozzo, R. V., & Birk, D. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806590200 · Cited by 224
Self-citationDecorin prevents metastatic spreading of breast cancer
Reed, C. C., Waterhouse, A., Kirby, S., Kay, P., Owens, R. T., McQuillan, D. J., & Iozzo, R. V. (2005) · Oncogene · doi:10.1038/sj.onc.1208329 · Cited by 209
Self-citation
Research works printed but not linked: 67
- Hanahan, 2011, Hallmarks of cancer. The next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 · DOI · Paper page
- Iozzo, 1996, Proteoglycans of the extracellular environment. Clues from the gene and protein side offer novel perspectives in molecular diversity and function, FASEB J, 10, 598, 10.1096/fasebj.10.5.8621059 · DOI · Paper page
- Iozzo, 1993, Altered proteoglycan gene expression and the tumor stroma, Cell. Mol. Life Sci, 49, 447, 10.1007/BF01923588 · DOI
- Neill, 2012, Decorin, a guardian from the matrix, Am. J. Pathol, 181, 380, 10.1016/j.ajpath.2012.04.029 · DOI · Paper page
- Reed, 2002, The role of decorin in collagen fibrillogenesis and skin homeostasis, Glycoconj. J, 19, 249, 10.1023/A:1025383913444 · DOI · Paper page
- Robinson, 2005, Influence of decorin and biglycan on mechanical properties of multiple tendons in knockout mice, J. Biomech. Eng, 127, 181, 10.1115/1.1835363 · doi:10.1115/1.1835363
- Ichii, 2012, The canonical Wnt pathway shapes niches supportive of hematopoietic stem/progenitor cells, Blood, 119, 1683, 10.1182/blood-2011-07-369199 · DOI
- Dunkman, 2013, Decorin expression is important for age-related changes in tendon structure and mechanical properties, Matrix Biol, 32, 3, 10.1016/j.matbio.2012.11.005 · DOI · Paper page
- Brandan, 2013, Role of skeletal muscle proteoglycans during myogenesis, Matrix Biol, 32, 289, 10.1016/j.matbio.2013.03.007 · DOI
- Ruoslahti, 1991, Proteoglycans as modulators of growth factor activities, Cell, 64, 867, 10.1016/0092-8674(91)90308-L · DOI · Paper page
- Iozzo, 1999, Decorin is a biological ligand for the epidermal growth factor receptor, J. Biol. Chem, 274, 4489, 10.1074/jbc.274.8.4489 · DOI · Paper page
- Goldoni, 2009, Decorin is a novel antagonistic ligand of the Met receptor, J. Cell Biol, 185, 743, 10.1083/jcb.200901129 · DOI · Paper page
- Schönherr, 2005, Decorin, a novel player in the insulin-like growth factor system, J. Biol. Chem, 280, 15767, 10.1074/jbc.M500451200 · DOI · Paper page
- Schaefer, 2007, Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-1 receptor and mammalian target of rapamycin, Am. J. Pathol, 170, 301, 10.2353/ajpath.2007.060497 · DOI
- Iozzo, 2011, Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling, J. Biol. Chem, 286, 34712, 10.1074/jbc.M111.262766 · DOI
- Morrione, 2013, Dichotomy of decorin activity on the insulin-like growth factor-I system, FEBS J, 280, 2138, 10.1111/febs.12149 · DOI · Paper page
- Khan, 2011, Decorin is a novel VEGFR-2-binding antagonist for the human extravillous trophoblast, Mol. Endocrinol, 25, 1431, 10.1210/me.2010-0426 · DOI · Paper page
- Schaefer, 2012, Small leucine-rich proteoglycans, at the crossroad of cancer growth and inflammation, Curr. Opin. Genet. Dev, 22, 56, 10.1016/j.gde.2011.12.002 · DOI · Paper page
- Nikitovic, 2012, The biology of small leucine-rich proteoglycans in bone pathophysiology, J. Biol. Chem, 287, 33926, 10.1074/jbc.R112.379602 · DOI · Paper page
- Seidler, 2012, The galactosaminoglycan-containing decorin and its impact on diseases, Curr. Opin. Struct. Biol, 22, 578, 10.1016/j.sbi.2012.07.012 · DOI
- Baghy, 2013, Decorin interferes with platelet-derived growth factor receptor signaling in experimental hepatocarcinogenesis, FEBS J, 280, 2150, 10.1111/febs.12215 · DOI
- Järvinen, 2010, Target-seeking antifibrotic compound enhances wound healing and suppresses scar formation in mice, Proc. Natl. Acad. Sci. U.S.A, 107, 21671, 10.1073/pnas.1016233107 · DOI
- Frey, 2013, Biological interplay between proteoglycans and their innate immune receptors in inflammation, FEBS J, 280, 2165, 10.1111/febs.12145 · DOI · Paper page
- Schaefer, 2008, Biological functions of the small leucine-rich proteoglycans. From genetics to signal transduction, J. Biol. Chem, 283, 21305, 10.1074/jbc.R800020200 · DOI · Paper page
- Buraschi, 2010, Decorin antagonizes Met receptor activity and down-regulates β-catenin and Myc levels, J. Biol. Chem, 285, 42075, 10.1074/jbc.M110.172841 · DOI
- Seidler, 2006, Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation, J. Biol. Chem, 281, 26408, 10.1074/jbc.M602853200 · DOI · Paper page
- Araki, 2009, Decorin suppresses bone metastasis in a breast cancer cell line, Oncology, 77, 92, 10.1159/000228253 · DOI
- Shintani, 2008, Decorin suppresses lung metastases of murine osteosarcoma, Oncol. Rep, 19, 1533
- Grant, 2002, Decorin suppresses tumor cell-mediated angiogenesis, Oncogene, 21, 4765, 10.1038/sj.onc.1205595 · DOI · Paper page
- Iozzo, 2011, Proteoglycans in cancer biology, tumour microenvironment and angiogenesis, J. Cell. Mol. Med, 15, 1013, 10.1111/j.1582-4934.2010.01236.x · DOI · Paper page
- De Luca, 1996, Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases, J. Biol. Chem, 271, 18961, 10.1074/jbc.271.31.18961 · DOI · Paper page
- Grant, 1993, Scatter factor induces blood vessel formation in vivo, Proc. Natl. Acad. Sci. U.S.A, 90, 1937, 10.1073/pnas.90.5.1937 · DOI · Paper page
- Neill, 2012, Decorin antagonizes the angiogenic network. Concurrent inhibition of Met, hipoxia-inducible factor-1α, and vascular endothelial growth factor A and induction of thrombospondin-1 and TIMP3, J. Biol. Chem, 287, 5492, 10.1074/jbc.M111.283499 · DOI · Paper page
- Neill, 2013, Decorin evokes rapid secretion of thrombospondin-1 in basal breast carcinoma cells via inhibition of Ras homolog gene family, member A/Rho-associated coiled-coil containing protein kinase 1, FEBS J, 280, 2353, 10.1111/febs.12148 · DOI
- Murphy-Ullrich, 2012, Thrombospondins in physiology and disease. New tricks for old dogs, Matrix Biol, 31, 152, 10.1016/j.matbio.2012.01.002 · DOI · Paper page
- Sweetwyne, 2012, Thrombospondin 1 in tissue repair and fibrosis. TGF-β-dependent and -independent mechanisms, Matrix Biol, 31, 178, 10.1016/j.matbio.2012.01.006 · DOI · Paper page
- Roberts, 2012, The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47, Matrix Biol, 31, 162, 10.1016/j.matbio.2012.01.005 · DOI · Paper page
- Theocharis, 2010, Proteoglycans in health and disease. Novel proteoglycan roles in malignancy and their pharmacological targeting, FEBS J, 277, 3904, 10.1111/j.1742-4658.2010.07800.x · DOI · Paper page
- Bi, 2008, Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation, Carcinogenesis, 29, 1435, 10.1093/carcin/bgn141 · DOI
- Bi, 2012, Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice, Carcinogenesis, 33, 326, 10.1093/carcin/bgr293 · DOI
- Iozzo, 1999, Cooperative action of germline mutations in decorin and p53 accelerates lymphoma tumorigenesis, Proc. Natl. Acad. Sci. U.S.A, 96, 3092, 10.1073/pnas.96.6.3092 · DOI
- Reed, 2002, Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin, Oncogene, 21, 3688, 10.1038/sj.onc.1205470 · DOI
- Tralhão, 2003, In vivo selective and distant killing of cancer cells using adenovirus-mediated decorin gene transfer, FASEB J, 17, 464
- Hu, 2009, Decorin suppresses prostate tumor growth through inhibition of epidermal growth factor and androgen receptor pathways, Neoplasia, 11, 1042, 10.1593/neo.09760 · DOI
- Buraschi, 2012, Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model, PLoS ONE, 7, e45559, 10.1371/journal.pone.0045559 · DOI
- Vecchione, 2009, MITOSTATIN, a putative tumor suppressor on chromosome 12q24.1, is down-regulated in human bladder and breast cancer, Oncogene, 28, 257, 10.1038/onc.2008.381 · DOI
- Fassan, 2011, Mitostatin is down-regulated in human prostate cancer and suppresses the invasive phenotype of prostate cancer cells, PLoS ONE, 6, e19771, 10.1371/journal.pone.0019771 · DOI
- Zhu, 2005, Decorin evokes protracted internalization and degradation of the EGF receptor via caveolar endocytosis, J. Biol. Chem, 280, 32468, 10.1074/jbc.M503833200 · DOI · Paper page
- Dagda, 2009, Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission, J. Biol. Chem, 284, 13843, 10.1074/jbc.M808515200 · DOI · Paper page
- Gordan, 2007, HIF and c-Myc. Sibling rivals for control of cancer cell metabolism and proliferation, Cancer Cell, 12, 108, 10.1016/j.ccr.2007.07.006 · DOI · Paper page
- Ishizaki, 1996, The small GTP-binding protein Rho binds to and activates a 160-kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase, EMBO J, 15, 1885, 10.1002/j.1460-2075.1996.tb00539.x · DOI · Paper page
- Kalas, 2005, Oncogenes and angiogenesis. Down-regulation of thrombospondin-1 in normal fibroblasts exposed to factors from cancer cells harboring mutant Ras, Cancer Res, 65, 8878, 10.1158/0008-5472.CAN-05-1479 · doi:10.1158/0008-5472.can-05-1479
- Goldoni, 2004, Biologically active decorin is a monomer in solution, J. Biol. Chem, 279, 6606, 10.1074/jbc.M310342200 · DOI · Paper page
- Teyssier, 2005, Activation of nuclear receptort coactivator PGC-1α by arginine methylation, Genes Dev, 19, 1466, 10.1101/gad.1295005 · DOI · Paper page
- Finck, 2006, PGC-1 coactivators. Inducible regulators of energy metabolism in health and disease, J. Clin. Invest, 116, 615, 10.1172/JCI27794 · DOI · Paper page
- Takahashi, 2001, DJ-1 positively regulates the androgen receptor by impairing the binding of PIASxα to the receptor, J. Biol. Chem, 276, 37556, 10.1074/jbc.M101730200 · DOI · Paper page
- Mizushima, 2011, Autophagy. Renovation of cells and tissues, Cell, 147, 728, 10.1016/j.cell.2011.10.026 · DOI · Paper page
- Kirkin, 2009, A role for ubiquitin in selective autophagy, Mol. Cell, 34, 259, 10.1016/j.molcel.2009.04.026 · DOI · Paper page
- Cossarizza, 1993, A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1), Biochem. Biophys. Res. Commun, 197, 40, 10.1006/bbrc.1993.2438 · DOI · Paper page
- Schmidt, 1983, Biosynthetic pathway of mitochondrial ATPase subunit 9 in Neurospora crassa, J. Cell Biol, 96, 248, 10.1083/jcb.96.1.248 · doi:10.1083/jcb.96.1.248
- Campbell, 2012, Mitochondrial transcription factor A regulates mitochondrial transcription initiation, DNA packaging and genome copy number, Biochim. Biophys. Acta, 1819, 921, 10.1016/j.bbagrm.2012.03.002 · DOI · Paper page
- Buraschi, 2013, Decorin causes autophagy in endothelial cells via Peg3, Proc. Natl. Acad. Sci. U.S.A, 110, E2582, 10.1073/pnas.1305732110 · DOI · Paper page
- Wang, 2011, Mitochondria removal by autophagy, Autophagy, 7, 297, 10.4161/auto.7.3.14502 · DOI · Paper page
- Kubli, 2012, Mitochondria and mitophagy. The yin and yang of cell death control, Circ. Res, 111, 1208, 10.1161/CIRCRESAHA.112.265819 · DOI · Paper page
- Goldoni, 2008, Tumor microenvironment. Modulation by decorin and related molecules harboring leucine-rich tandem motifs, Int. J. Cancer, 123, 2473, 10.1002/ijc.23930 · DOI · Paper page
- Perdomo, 2008, Hepatocyte growth factor is a novel stimulator of glucose uptake and metabolism in skeletal muscle cells, J. Biol. Chem, 283, 13700, 10.1074/jbc.M707551200 · DOI · Paper page
- Cerqua, 2010, Trichoplein/mitostatin regulates endoplasmic reticulum-mitochondria juxtaposition, EMBO Reports, 11, 854, 10.1038/embor.2010.151 · DOI · Paper page
Cited by
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Self-citationGuidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897
Self-citationYuan, Z., Li, Y., Zhang, S., Wang, X., Dou, H., Yu, X., Zhang, Z., Yang, S., & Xiao, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01744-8 · Cited by 977
The extracellular matrix in breast cancer
Insua-Rodríguez, J., & Oskarsson, T. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.017 · Cited by 470
Proteoglycan Chemical Diversity Drives Multifunctional Cell Regulation and Therapeutics
Karamanos, N. K., Piperigkou, Z., Theocharis, A. D., Watanabe, H., Franchi, M., Baud, S., Brézillon, S., Götte, M., Passi, A., Vigetti, D., et al. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00354 · Cited by 367
Self-citationGubbiotti, M. A., Vallet, S. D., Ricard-Blum, S., & Iozzo, R. V. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.09.009 · Cited by 227
Self-citationProteoglycans remodeling in cancer: Underlying molecular mechanisms
Theocharis, A. D., & Karamanos, N. K. (2019) · Matrix Biology · doi:10.1016/j.matbio.2017.10.008 · Cited by 203
Metadata
- Authors
- Neill, T., Torres, A., Buraschi, S., Owens, R. T., Hoek, J. B., Baffa, R., & Iozzo, R. V.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 289
- Issue
- 8
- Pages
- 4952-4968
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1969889291
- Cited by
- 103
- References
- 10
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 2410 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.